Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C72H101N17O26 |
Molecular Weight | 1620.6706 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@H](C)CC(O)=O
InChI
InChIKey=DOAKLVKFURWEDJ-QCMAZARJSA-N
InChI=1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45-,46+,47+,48+,49+,50-,60+,61+/m1/s1
Molecular Formula | C72H101N17O26 |
Molecular Weight | 1620.6706 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 4 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:00:48 UTC 2023
by
admin
on
Sat Dec 16 17:00:48 UTC 2023
|
Record UNII |
NWQ5N31VKK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175509
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
NDF-RT |
N0000175508
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
WHO-VATC |
QJ01XX09
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
NCI_THESAURUS |
C2363
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CUBICIN (AUTHORIZED: ENDOCARDITIS, BACTERIAL)
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
WHO-ATC |
J01XX09
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CUBICIN (AUTHORIZED: BACTEREMIA)
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
NDF-RT |
N0000175508
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
||
|
LIVERTOX |
NBK548746
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
NWQ5N31VKK
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
NWQ5N31VKK
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
21585658
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
783
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
DTXSID1041009
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
22299
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
Y-79
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
Daptomycin
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
D017576
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
C47470
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
DB00080
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
600103
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
SUB06910MIG
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
DAPTOMYCIN
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL387675
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
103060-53-3
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
m4093
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
6127
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY | |||
|
100000085430
Created by
admin on Sat Dec 16 17:00:49 UTC 2023 , Edited by admin on Sat Dec 16 17:00:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
METABOLIC ENZYME -> NON-INHIBITOR |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||